Back to Main Menu
Products & Services
MBMbio-intelligence
Digital Pathology Slide Scanner
MBMbio-intelligence Digital Pathology Slide Scanner
In order to fully maximize the potential of machine and deep learning applications in digital pathology, the images acquired using digital scanners need to be optimized for “measurements”, rather than “viewing”. This led us to create the MBMbio-intelligence, the world’s first designed for A.I. digital pathology scanner.
The MBMbio-intelligence hardware and software are integrated and optimized to acquire accurate and precise quality cell and tissue images, and comes with various filter lenses to improve fine contrast of subcellular organelles. At the same time, it has AI adaptive precision measurement mode and conventional scanning mode. It is suitable for AI digital pathology research and study and clinical application, and can also meet the routine operation needs of slides viewing, teaching and remote consultation.
The MBMbio-intelligence was jointly developed by MBM with technical support from the Institute for Cancer Genetics & Informatics (Norway) and is available in 5-slides and 400-slides models, suitable for research and clinical applications.






Test Kits
MBM’s biomarker system Nucleotyping, DNA Ploidy and Stroma uses standard test kits and experimental procedures to ensure rigorous and accurate analysis results.

Latest Blog Posts
News and healthcare tips
MBMbio announced residency at JLABS @ Shanghai
MBMbio announced residency at JLABS @ ShanghaiDecember 1, 2021Shanghai China, December 1, 2021 – MBMbio announced today that, effective...
Red Blood Cells Offer a Breakthrough in Liquid Biopsy Technology
The Often Neglected Red Blood Cell Offers a Breakthrough in Liquid Biopsy Technology for Early Stage Cancer Detection
Colorectal Cancer Recurrence Risk Assessment Marker Announcement
MBM’s “Colorectal Cancer Recurrence Risk Assessment Marker” announced at the National Colorectal Surgery Symposium
MBM recognized as a Top 30 enterprise
MBM recognized as a Top 30 enterprise in the 2020 National Innovation & Entrepreneurship Competition